“But Nature Started It”: Examining Taubenberger and Morens’ View on Influenza A Virus and Dual-Use Research of Concern

Código QR

“But Nature Started It”: Examining Taubenberger and Morens’ View on Influenza A Virus and Dual-Use Research of Concern

Guardado en:

Detalles Bibliográficos
Autor principal:	Nicholas G. Evans
Formato:	article
Lenguaje:	EN
Publicado:	American Society for Microbiology 2013
Materias:	Microbiology QR1-502
Acceso en línea:	https://doaj.org/article/52ee2ec78af2487989d4bbd3c3b429bd
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Reply to “‘But Nature Started It’: Examining Taubenberger and Morens’ View on Influenza A Virus and Dual-Use Research of Concern”
por: Jeffery K. Taubenberger, et al.
Publicado: (2013)

Moren er Død, Moren, Leve...
por: Michael Nebeling
Publicado: (2015)

Redaction of Sensitive Data in the Publication of Dual Use Research of Concern
por: Arturo Casadevall, et al.
Publicado: (2014)

Dual-Use Research of Concern (DURC) Review at American Society for Microbiology Journals
por: Arturo Casadevall, et al.
Publicado: (2015)

Dual-Use Research of Concern (DURC) Review at American Society for Microbiology Journals and Its Effect on Other Organizations
por: Stuart Nightingale
Publicado: (2015)

Mammalian-Transmissible H5N1 Influenza: the Dilemma of Dual-Use Research
por: Robert G. Webster
Publicado: (2012)

A Brain Drain due to Increased Regulation of Influenza Virus Research Is Highly Speculative
por: Derrin Culp
Publicado: (2014)

Research on Highly Pathogenic H5N1 Influenza Virus: The Way Forward
por: Anthony S. Fauci
Publicado: (2012)

Reply to “A Brain Drain due to Increased Regulation of Influenza Virus Research Is Highly Speculative”
por: Arturo Casadevall, et al.
Publicado: (2014)

The Pause on Avian H5N1 Influenza Virus Transmission Research Should Be Ended
por: Ron A. M. Fouchier, et al.
Publicado: (2012)

mSphere of Influence: Redefining an Influenza Virus—How Different Are Influenza Viruses and Extracellular Vesicles?
por: Seema S. Lakdawala
Publicado: (2019)

Influenza Viruses: Breaking All the Rules
por: Jeffery K. Taubenberger, et al.
Publicado: (2013)

Intrahost Dynamics of Antiviral Resistance in Influenza A Virus Reflect Complex Patterns of Segment Linkage, Reassortment, and Natural Selection
por: Matthew B. Rogers, et al.
Publicado: (2015)

Influenza Virus Resistance to Human Neutralizing Antibodies
por: James E. Crowe
Publicado: (2012)

The Novel Human Influenza A(H7N9) Virus Is Naturally Adapted to Efficient Growth in Human Lung Tissue
por: Jessica Knepper, et al.
Publicado: (2013)

After COVID-19 We Will Need a New Research System. We Need To Start Planning Now
por: Stefano Bertuzzi, et al.
Publicado: (2020)

Using Sequence Data To Infer the Antigenicity of Influenza Virus
por: Hailiang Sun, et al.
Publicado: (2013)

Plasticity of the Influenza Virus H5 HA Protein
por: Huihui Kong, et al.
Publicado: (2021)

Dual function of CD81 in influenza virus uncoating and budding.
por: Jiang He, et al.
Publicado: (2013)

Rapid Proliferation of Pandemic Research: Implications for Dual-Use Risks
por: Sriharshita Musunuri, et al.
Publicado: (2021)

Rocio Virus: An Updated View on an Elusive Flavivirus
por: Marielena Vogel Saivish, et al.
Publicado: (2021)

Influenza Viruses and mRNA Splicing: Doing More with Less
por: Julia Dubois, et al.
Publicado: (2014)

Detection of Evolutionarily Distinct Avian Influenza A Viruses in Antarctica
por: Aeron C. Hurt, et al.
Publicado: (2014)

Complete and Incomplete Genome Packaging of Influenza A and B Viruses
por: Sumiho Nakatsu, et al.
Publicado: (2016)

Reconstruction of the 1918 Influenza Virus: Unexpected Rewards from the Past
por: Jeffery K. Taubenberger, et al.
Publicado: (2012)

Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain
por: John Steel, et al.
Publicado: (2010)

Bacterial Lipopolysaccharide Destabilizes Influenza Viruses
por: Christopher Bandoro, et al.
Publicado: (2017)

Correction for Knepper et al., The Novel Human Influenza A(H7N9) Virus Is Naturally Adapted to Efficient Growth in Human Lung Tissue
por: Jessica Knepper, et al.
Publicado: (2014)

Obesity-Related Microenvironment Promotes Emergence of Virulent Influenza Virus Strains
por: Rebekah Honce, et al.
Publicado: (2020)

A universal dual mechanism immunotherapy for the treatment of influenza virus infections
por: Xin Liu, et al.
Publicado: (2020)

Examining immune arms in mice immunized with site-specific influenza virus mutants
por: S. G. Markushin, et al.
Publicado: (2020)

The Apocalypse as a Rhetorical Device in the Influenza Virus Gain-of-Function Debate
por: Arturo Casadevall, et al.
Publicado: (2014)

Why Do Influenza Virus Subtypes Die Out? A Hypothesis
por: Peter Palese, et al.
Publicado: (2011)

Antibody Landscape Analysis following Influenza Vaccination and Natural Infection in Humans with a High-Throughput Multiplex Influenza Antibody Detection Assay
por: Zhu-Nan Li, et al.
Publicado: (2021)

An Intranasal Virus-Like Particle Vaccine Broadly Protects Mice from Multiple Subtypes of Influenza A Virus
por: Louis M. Schwartzman, et al.
Publicado: (2015)

Pathogenicity of the Novel A/H7N9 Influenza Virus in Mice
por: Chris Ka Pun Mok, et al.
Publicado: (2013)

Influenza Gain-of-Function Experiments: Their Role in Vaccine Virus Recommendation and Pandemic Preparedness
por: S. Schultz-Cherry, et al.
Publicado: (2014)

Cathepsin W Is Required for Escape of Influenza A Virus from Late Endosomes
por: Thomas O. Edinger, et al.
Publicado: (2015)

Studies on Influenza Virus Transmission between Ferrets: the Public Health Risks Revisited
por: Ron A. M. Fouchier
Publicado: (2015)

The 2009 H1N1 Pandemic Influenza Virus: What Next?
por: David M. Morens, et al.
Publicado: (2010)